Roche (4 pharmaceutical products) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Roche (4 pharmaceutical products) General Information

Description

A portfolio of pharmaceutical products. The portfolio comprises of four products namely Marcoumar, an anticoagulant, Torem , a loop diuretic, Tilcotil , a drug for the treatment of painful inflammatory and degenerative disorders of the musculoskeletal system and Aurorix , a well-known antidepressant.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche (4 pharmaceutical products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request a free trial

Roche (4 pharmaceutical products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request a free trial